Successful Use of Nivolumab in a Patient with Head and Neck Cancer After Allogeneic Bone Marrow Transplantation

Recently, programmed cell death 1(PD-1) inhibitors have shown a significant curative effect in the treatment of most solid cancers and some hematological malignancies. The effects of PD-1 inhibitors in recurrent head and neck squamous cell carcinoma (HNSCC) have also been confirmed. However, there i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Xiaopei, Lu, Ning, Tong, Zhongsheng, Shi, Yehui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882438/
https://www.ncbi.nlm.nih.gov/pubmed/33603397
http://dx.doi.org/10.2147/OTT.S267022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882438/
https://www.ncbi.nlm.nih.gov/pubmed/33603397
http://dx.doi.org/10.2147/OTT.S267022

Ejemplares similares